Heron Therapeutics, Inc.【HRTX】 業績推移・財務諸表

機能の使い方
(単位:千ドル) 2Q11 3Q11 4Q11 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 3Q25 4Q25
売上高 - - - - - - - - - - - - - - - - - - - - - - 1,279 3,632 8,510 8,572 10,053 11,567 17,277 19,786 28,844 31,602 36,659 42,600 35,083 25,400 22,700 20,000 20,605 20,000 22,400 23,200 20,646 23,500 27,630 26,557 30,028 29,615 31,762 31,434 34,233 34,670 36,024 32,810 40,781 38,903 37,200 38,213 40,588
売上成長率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - 19.1 12.2 3.3 16.5 -0.5
売上原価 - - - - - - - - - - - - - - - - - - - - - - 35 1,186 1,013 1,051 1,338 3,133 5,231 7,576 11,572 14,962 13,588 17,195 15,874 10,622 9,005 7,170 9,392 9,207 14,522 11,351 10,941 11,355 16,175 14,717 12,627 16,854 20,158 18,208 9,885 8,444 10,518 9,458 10,228 8,457 9,857 11,914 11,119
売上総利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 13,226 24,348 26,226 25,506 23,352 30,553 30,446 27,343 26,299 29,469
売上総利益率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 74.9 78.3 73.5 68.8 72.6
研究開発費 1,282 2,929 2,855 3,329 3,067 - - 6,772 10,531 5,885 9,592 11,771 14,427 14,731 14,195 14,504 16,175 14,241 16,263 16,092 27,286 30,242 29,505 33,384 28,597 28,844 47,757 39,561 30,159 30,421 39,891 42,972 41,425 34,708 48,277 36,894 44,004 49,182 44,453 38,116 35,233 28,595 28,877 42,070 28,834 25,545 11,057 13,817 17,572 13,558 10,950 4,608 4,432 4,465 3,178 2,279 2,934 3,470 3,746
営業費用 1,791 4,089 4,118 4,769 4,380 - 8,628 12,752 15,209 12,664 13,832 17,322 18,791 18,953 19,495 20,360 23,014 22,491 31,060 33,312 43,066 47,734 48,082 52,931 50,565 49,886 71,943 63,557 56,130 61,566 80,158 96,302 88,438 77,477 94,445 78,134 78,417 78,349 81,901 72,132 82,912 74,938 74,192 86,380 77,128 68,439 50,383 62,678 74,165 38,155 34,568 31,024 31,951 27,810 26,380 27,292 28,980 30,392 29,431
営業利益 -1,540 -4,089 -4,118 -4,769 -4,380 - - -12,752 -15,209 -12,664 -13,831 -17,322 -18,791 -18,953 -19,495 -20,360 -23,014 -22,491 -31,060 -33,312 -43,066 -47,734 -46,803 -49,299 -42,055 -41,314 -61,890 -51,990 -38,853 -41,780 -51,314 -64,700 -51,779 -34,853 -59,362 -52,734 -55,749 -58,384 -61,296 -52,114 -60,469 -51,708 -53,537 -62,923 -49,498 -41,882 -20,355 -33,063 -42,403 -24,929 -10,220 -4,798 -6,445 -4,458 4,173 3,154 -1,637 -4,093 38
営業利益率 (%) - - - - - - - - - - - - - - - - - - - - - - 10.2 8.1 -4.4 -10.7 0.1
経常(税引前)利益 - - - -4,830 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
純利益 -1,932 -4,202 -4,261 -4,921 -4,569 -6,121 -7,737 -12,953 -15,413 -12,873 -14,044 -17,538 -19,011 -19,194 -20,624 -20,570 -23,107 -22,672 -31,242 -33,445 -43,226 -48,509 -47,963 -50,329 -42,799 -41,866 -62,490 -52,265 -38,670 -38,346 -49,559 -63,012 -50,222 -33,595 -57,920 -51,579 -55,190 -58,228 -62,281 -52,614 -61,015 -52,408 -54,646 -63,888 -56,359 -41,908 -19,869 -32,800 -42,059 -25,008 -10,724 -3,160 -9,235 -4,848 3,663 2,635 -2,381 -17,495 -2,954
純利益率(%) - - - - - - - - - - - - - - - - - - - - - - 9.0 6.8 -6.4 -45.8 -7.3
一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -0.55 -0.38 -0.13 -0.27 -0.35 -0.17 -0.05 -0.02 -0.06 -0.03 0.02 0.02 -0.02 -0.1 -0.01
希薄化後一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -0.55 -0.38 -0.13 -0.27 -0.35 -0.17 -0.05 -0.02 -0.06 -0.03 0.02 0.01 -0.02 -0.1 -0.01
EBITDA - - - - - - - - - - - - - - - - - - - - - - - - - - 4,762 3,705 -1,026 -3,478 561
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - - - - - - - - - 11.7 9.5 -2.8 -9.1 1.4